Amazon is folding its Amazon Clinic telehealth service into its primary care business One Medical, the company announced on Thursday.
The company explained in today’s blog post that, to simplify Amazon’s primary care offering for customers, the service has now been rebranded to Amazon One Medical Pay-per-visit, and now offers more affordable per-visit pricing. Customers can pay $49 for a video call visit or $29 to text message a doctor.
Amazon’s continued bet on its healthcare strategy comes as health tech startups, particularly in the virtual care space, are still emerging. The company’s offering may impact startups with similar services, such as Carbon Health, Galileo and Summer Health, among others.
Under the One Medical brand, Amazon is offering customers two options: a telehealth service for over 30 common conditions (such as acne, eczema, the flu, pink eye, seasonal allergies and a sinus infection), or a paid membership to get on-demand virtual care and next-day in-person appointments at the more than 150 One Medical primary care offices across the U.S. The membership costs $9 per month or $99 per year for Prime members and $199 per year for all other customers.
The pay-per-visit service is a convenient option for customers who don’t live near an Amazon One Medical physical office or already have a primary care provider, but need fast and easy access to address a one-off condition. Customers don’t need insurance and FSA/HSA payment is accepted.
The retail giant has increased its investment in healthcare in recent years, including the nearly $4 billion acquisition of One Medical. Amazon launched Clinic in 2022 as a virtual health storefront for customers to pay for one-time telehealth care services. That same year, Amazon shut down its employee-focused virtual primary care business Amazon Care, which attempted to blend telehealth and in-person medical services for workers.
Meanwhile, other large companies are pulling back from the space. In April, Walmart shut down its health center and virtual care service.
Kommentar